Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease

Inki Moon; So-Ryoung Lee; Eue-Keun Choi; Euijae Lee; Jin‐Hyung Jung; Kyungdo Han; Myung‐Jin Cha; Seil Oh; Professor Gregory Lip

doi:10.3390/jcm8101624

Abstract

1 min read

In this nationwide Asian AF population with EHRA type 2 VHDs, NOAC use was associated with lower risks of ischemic stroke, major bleeding, all-cause death, and the composite outcome compared to warfarin use.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

P4780Effectiveness and safety of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease

Inki Moon, S R Lee, Eunsuk Choi, E J Lee, Jin‐Hyung Jung, Kyungdo Han, M J, Seil Oh, Professor Gregory Lip

Article2019

Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage

So-Ryoung Lee, Eue-Keun Choi, Soonil Kwon, Jin‐Hyung Jung, Kyungdo Han, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip

Article2019

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage

Peter Brønnum Nielsen, Flemming Skjøth, Mette Søgaard, Jette Nordstrøm Kjældgaard, Professor Gregory Lip, Torben Bjerregaard Larsen

Article2019

Non–Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function

Seil Oh, Professor Gregory Lip, So-Ryoung Lee, Eue-Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha

Article2019

Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation

So-Ryoung Lee, Eue-Keun Choi, Soonil Kwon, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip